How to Test for Ureaplasma in Males

The most reliable way to test for Ureaplasma in males is a nucleic acid amplification test, usually a PCR assay, run on a first-void urine sample. This method is more sensitive than traditional culture and can distinguish between the two human-associated species, Ureaplasma urealyticum and Ureaplasma parvum, a distinction that matters for clinical decisions. But whether you should get tested at all depends on your symptoms, your fertility goals, and what your doctor suspects is going on, because many men carry these bacteria without ever developing problems.

When Testing Actually Makes Sense

Ureaplasma lives in the urogenital tract of a large fraction of sexually active adults without causing any symptoms. That high rate of asymptomatic carriage is precisely what makes the clinical picture so murky. A position statement from the European STI Guidelines Editorial Board concluded that routine testing of asymptomatic men and women is not recommended, because there is no clear evidence that detecting and treating colonization does more good than harm.¹ The majority of carriers never develop disease, so a positive result in someone with no complaints can lead to unnecessary antibiotic treatment and anxiety.

Testing becomes reasonable in a few specific scenarios. The first is nongonococcal urethritis (NGU), where standard tests for chlamydia and gonorrhea come back negative but you still have urethral discharge, burning during urination, or other signs of inflammation. Research at an STD clinic in Seattle found a significant association between U. urealyticum and NGU in men, particularly those with fewer lifetime sexual partners.² The second scenario is unexplained male infertility: if semen parameters are abnormal and the usual causes have been ruled out, checking for Ureaplasma in semen or urine can be worthwhile. The third is when a sexual partner has been diagnosed with Ureaplasma-related symptoms and your doctor wants to test both of you before deciding on treatment.

Outside those situations, ordering a Ureaplasma test “just to check” is generally discouraged. A positive result in someone with no symptoms does not necessarily mean treatment is needed, and the scientific community remains genuinely divided on when asymptomatic detection should trigger intervention.³

First-Void Urine Is the Preferred Sample

For most male Ureaplasma testing, the sample of choice is first-void urine (FVU), meaning the initial stream when you urinate, typically the first 10 to 20 milliliters. This portion of the urine stream washes organisms out of the urethra, concentrating bacterial DNA where the test can pick it up. A study comparing first-void urine with urogenital swabs for PCR-based detection of related genital pathogens found that FVU was the most sensitive diagnostic specimen.⁴ Urine outperformed urethral swabs for PCR detection in that cohort.

The practical upside is obvious: peeing into a cup is far less uncomfortable than having a thin swab inserted into the urethra. Most clinics and labs now default to FVU for male genital pathogen testing unless there is a specific reason to swab. If you are asked to provide a first-void urine sample, you will usually be told not to urinate for at least one to two hours beforehand so the urine has had time to accumulate bacteria from the urethral lining.

Some clinics still use urethral swabs, and these can work. One study found that quantitative PCR on male urethral swabs had about 89% sensitivity for Ureaplasma compared with culture.⁵ That is still good, but the swab experience is unpleasant enough that most men and most clinicians prefer urine when it is an option.

Semen as a Diagnostic Specimen

When the reason for testing is infertility rather than urethritis, semen itself can also be used. Research comparing semen and first-void urine found greater than 95% concordance and very good agreement for detecting ureaplasmas with PCR, meaning the two specimen types picked up essentially the same organisms.⁶ Semen testing makes particular sense when you are already providing a sample for a standard semen analysis, because the lab can run both tests from a single collection. U. urealyticum in semen has been associated with lower sperm concentration, reduced forward motility, and poorer sperm morphology compared with Ureaplasma-negative samples.⁷

If a fertility workup reveals abnormal sperm parameters and Ureaplasma is detected, antibiotic treatment may improve those numbers. One study tracking semen analysis before and after antibiotic therapy for Ureaplasma-related infection found that sperm concentration and progressive motility both improved, though the motility improvement took about 30 days after treatment to become apparent.⁸ This is one area where testing an asymptomatic man may carry a clear benefit: even without urinary symptoms, clearing the infection could help restore fertility.

PCR Versus Culture and Other Methods

Three main laboratory approaches exist for detecting Ureaplasma, and they differ considerably in speed, sensitivity, and the kind of information they provide.

PCR (polymerase chain reaction): The current gold standard for detection. PCR amplifies bacterial DNA, so it can find Ureaplasma even when the organism count is low. An early comparison study found that PCR detected U. urealyticum in 12 clinical samples where culture caught only five definite positives, and PCR returned results much faster.⁹ Modern real-time (quantitative) PCR assays can also tell the lab how much bacterial DNA is present, which some researchers believe helps distinguish harmless carriage from an active infection.¹⁰
Culture: Growing Ureaplasma on special media used to be the standard method. Culture is still available and has the advantage of producing a living isolate that can be tested for antibiotic susceptibility. The downside is lower sensitivity and a longer turnaround time, usually 48 hours or more. One commercial culture-based kit, MYCO WELL D-ONE, showed around 92% sensitivity and 96% specificity for Ureaplasma species compared with quantitative PCR.¹¹
Species-specific PCR: Standard PCR might only report “Ureaplasma positive.” Newer assays using primers that target the urease gene or other species-specific regions can separately identify U. urealyticum and U. parvum.¹² This distinction is clinically relevant because the two species appear to carry different levels of risk.

If you have a say in which test your doctor orders, ask whether the lab uses a PCR-based method that can differentiate the two species. Not all labs do, and a result that simply says “Ureaplasma detected” leaves an important question unanswered.

Why the Species Matters

Until the early 2000s, what we now call U. parvum and U. urealyticum were considered two variants (biovars) of the same organism. PCR-based assays targeting the 16S rRNA gene and the multiple-banded antigen gene eventually confirmed they should be classified as separate species.¹³ This matters because the accumulating evidence points to U. urealyticum as the more likely pathogen in men. Associations with NGU and with impaired sperm quality are stronger for U. urealyticum than for U. parvum, which is found more often as an innocent bystander.³

If your test returns “U. parvum detected” and you have no symptoms, there is even less reason to treat than if U. urealyticum is found. And if the test does not distinguish between species at all, you and your doctor are working with incomplete information. Some clinicians treat any Ureaplasma finding; others want to know the species before committing to antibiotics. Knowing which species you carry can save you an unnecessary course of medication.

Co-infections and Broader STI Panels

Ureaplasma rarely travels alone. In a study of male outpatients in China, the most common co-infection among men with Ureaplasma urealyticum was gonorrhea, found together in about 15% of the sample, followed by chlamydia co-infection at about 4%.¹⁴ Another study found that when both U. urealyticum and Mycoplasma hominis were present, the chance of also carrying Chlamydia trachomatis increased, while neither organism alone tracked with chlamydia.¹⁵

The practical takeaway is that if your doctor is testing for Ureaplasma, you should probably be tested for chlamydia, gonorrhea, and Mycoplasma genitalium at the same time, especially if you have urethritis symptoms. Many multiplex PCR panels can detect all of these organisms from a single urine sample or swab, so there is no reason to test for one and ignore the others. A case report of an HIV-positive man who tested positive for C. trachomatis, M. genitalium, M. hominis, and Ureaplasma simultaneously on a rectal swab underscores how often these organisms overlap in the same person.¹⁶ Men who have sex with men may also benefit from testing at rectal and oropharyngeal sites, not just urine, depending on exposure history.

Handling and Transporting Your Sample

One concern people have with at-home collection kits or samples that need to be mailed to a lab is whether the bacteria’s DNA degrades before it reaches the testing instrument. A study that tracked Ureaplasma DNA stability found that extracted DNA stored at refrigerator temperature (4°C) remained stable for at least 28 days, with no significant drop in detectable concentration regardless of whether the starting bacterial load was low, medium, or high.¹⁷ That means if a sample is collected and kept cool, it can be shipped to a distant lab without significant loss of accuracy.

Where things can go wrong is leaving a sample at room temperature for extended periods, especially in warm weather, or contaminating the specimen with midstream urine instead of collecting the first-void portion. If you are using a mail-in testing service, follow the instructions carefully about which part of the urine stream to capture and whether to refrigerate the sample before shipping. Most reputable kits include a transport medium or preservative buffer designed to keep DNA intact during transit.

Self-Collection and At-Home Kits

The good news for men who want to test without visiting a clinic is that first-void urine is a self-collected specimen by definition. You do not need a clinician to collect it. Research has confirmed that self-collected FVU serves as a reliable marker for the presence of ureaplasmas and mycoplasmas in the genital tract and can be used to detect asymptomatic carriers.⁶

Several direct-to-consumer testing companies now offer Ureaplasma PCR panels that you order online, collect at home, and mail back. The laboratory methods used in these kits are typically the same validated PCR assays used in clinical settings. What you lose by going the at-home route is clinical context: a doctor ordering the test in person can factor in your symptoms, sexual history, and the results of a physical exam. A kit mailed to your door cannot do that. If your results come back positive, you will still need a clinician to prescribe treatment and decide whether further testing is warranted.

Partner Testing and Concordance

Because Ureaplasma is transmitted sexually, the question of whether your partner should also be tested comes up frequently. A study comparing infertile and fertile couples found that concordance of U. urealyticum between partners was about 32% in infertile couples, compared with roughly 13% in fertile couples.¹⁸ That higher concordance in the infertile group suggests the organism is being shared between partners and may be contributing to the fertility problem. If only one partner is treated, reinfection from the untreated partner is a real possibility.

In the broader population, U. urealyticum carriage in male partners of women with and without bacterial vaginosis was roughly similar (around a quarter of men in both groups), indicating that carriage in men does not always track with a partner’s symptoms.¹⁹ The clinical picture around partner notification for Ureaplasma is much less clear-cut than it is for chlamydia or gonorrhea, where treating both partners is standard. For infertile couples, though, testing and treating both partners simultaneously makes intuitive and clinical sense.

Antibiotic Susceptibility Testing

When Ureaplasma is confirmed and treatment is warranted, the typical first-line antibiotic is doxycycline, followed by azithromycin or a fluoroquinolone if doxycycline fails. But resistance is a growing problem. Research on clinical Ureaplasma isolates has identified specific genetic mutations that confer resistance to both macrolide antibiotics (like erythromycin and azithromycin) and fluoroquinolones (like levofloxacin and ciprofloxacin).²⁰ A study covering North American isolates from 2012 to 2023 found that the most common resistance mutations appeared in the genes encoding ribosomal structures and in the DNA gyrase-related gene parC.²¹

What this means for you as a patient is that if a first course of antibiotics does not clear your Ureaplasma infection, your doctor may need to order susceptibility testing to figure out which drugs the organism is still vulnerable to. Culture-based susceptibility testing is the traditional method for this, since growing the bacteria allows them to be exposed to different antibiotics directly. Molecular resistance testing, which looks for known resistance mutations in the bacterial DNA, is faster but cannot catch every possible resistance mechanism. Some labs offer a concurrent approach: titrating the organism in culture while simultaneously checking for genetic resistance markers.²² If you have persistent symptoms after treatment, ask your doctor whether susceptibility testing has been done or should be.

Rectal and Oropharyngeal Testing

Most Ureaplasma testing in men focuses on the urethra, for the simple reason that urethritis is the most recognized clinical scenario. But Ureaplasma can colonize other mucosal sites. The case report mentioned earlier found all four tested organisms, including Ureaplasma, on a rectal swab.¹⁶ Routine guidelines do not yet call for rectal or throat testing for Ureaplasma the way they do for chlamydia and gonorrhea in men who have sex with men, but clinicians investigating persistent or unusual symptoms at those sites may choose to test. If you have rectal symptoms and your urethral tests are negative, it is worth discussing extragenital testing with your provider.

The evidence base here is still thin. Most of what we know about Ureaplasma at non-urethral sites comes from case reports and small observational studies rather than large cohort research. That said, as multiplex PCR panels become more widely available and cheaper, routine multi-site testing may become more common in the coming years, especially in sexual health clinics serving populations with higher STI prevalence.